REGN vs ROOT
Regeneron Pharmaceuticals Inc (REGN) versus Root Inc (ROOT) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Root Inc (ROOT) is a insurance - property & casualty company listed on NASDAQ.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported ROOT revenue for 2024-12-31 was $1.18B. Net income was $30.9M. Revenue was up 158.6% from 2023-12-31 to 2024-12-31. ROOT currently screens at market cap $767.6M and trailing P/E 14.3.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. ROOT currently screens at market cap $767.6M and trailing P/E 14.3.
Not investment advice. Open the REGN and ROOT stock pages for the full models.
Not investment advice.